National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/12/2021 release of VAERS data:

This is VAERS ID 1380072

Government Disclaimer on use of this data

Case Details

VAERS ID: 1380072 (history)  
Form: Version 2.0  
Age: 46.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-06-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Eastern Cooperative Oncology Group performance status, Neoplasm progression, SARS-CoV-2 test
SMQs:, Malignancy related conditions (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-07
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Adenocarcinoma; Cachexia; Lung metastases; Lymphatic system neoplasm (Malignant neoplasm of lymph nodes of several regions); Metastasis; Ovarian cancer metastatic
Diagnostic Lab Data: Test Name: ECOG; Result Unstructured Data: Test Result:3-4; Test Date: 20210507; Test Name: COVID-19 rapid POC test; Test Result: Negative
CDC Split Type: HUPFIZER INC2021628086

Write-up: death; This is as spontaneous report received from a contactable Healthcare Professional downloaded from the Regulatory Authority-WEB. The regulatory authority report number is HU-OGYI-344521. A 46-year-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine (nucleoside modified)/Tozinameran (COMIRNATY) concentrate for dispersion for injection, strength: 1 dose (0.3 mL) containing 30 micrograms of COVID-19 mRNA Vaccine, intramuscularly, in left arm, batch number: EW4815 on 17Apr2021, at 46 years of age. No events occurred after vaccination. Medical history included multiple metastatic high-grade serous ovarian carcinoma. Malignant neoplasm of lymph nodes of several regions, secondary malignancy of lung, adenocarcinoma, pancreatic metastasis. From 22Jan2021, the size and number of the lymph nodes increased. From 03Feb2021, the patient was in hospice care. In addition to severe cachexia (from 2021), Oncology 3-4 performance status developed, followed by symptomatic therapy. The patient was admitted to hospital on 07May2021 in moribund condition and died that same day at 17:55. A COVID-19 rapid test performed on 07May2021 resulted negative. Sender Comment: The patient died in metastatic high-grade serous ovarian carcinoma 20 days after COMIRNATY vaccination. There is no information whether autopsy was done. The event and COMIRNATY vaccination are not related. The case is serious due to fatal outcome. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: The patient''s demise is unrelated to BNT162B2 vaccine, being rather the fatal evolution of the underlying very advanced malignancy (ovarian carcinoma).; Reported Cause(s) of Death: Neoplasm progression

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166